| Tag | Content |
|---|
EnhancerAtlas ID | HS073-12611 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr6:106573730-106574590 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HNF4G | MA0484.1 | chr6:106573786-106573801 | AAAGGCCAAAGGCCA | + | 7.21 | | SPI1 | MA0080.4 | chr6:106574040-106574054 | AACTTCCTCTTTCA | - | 6.03 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_15273 | chr6:106573797-106574940 | CD4_Memory_Primary_7pool | | SE_19548 | chr6:106573468-106574534 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_56020 | chr6:106573553-106575958 | u87 | | SE_58834 | chr6:106530700-106671989 | Ly3 | | SE_62631 | chr6:106531123-106575028 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH06I106125 | chr6 | 106573591 | 106574783 |
|
Enhancer Sequence | CACTCCCTTG GGCAACAGAG TGAGAGTCTG TCTAAAAAAA AAAAAAGAAA TGTAACAAAG 60
GCCAAAGGCC AAAGTCCCCC GAATTTTGTC ACCCCCTTTC TCTTTTTGCT ATGCACATGA 120
GTCCCGCTGA GGTGTGTGAT CAAGTGAGCC CTCTGAGGTG TGTGATCAAG TAGGTCTCTG 180
GGCACCGAGC CCACTGGCTG CGCTGGCAGC CCCCTCACTT CTCCTGGGCA TGGAGTCCCA 240
GCACCTTCCT CACCTGAGTC TCATCTGTGT GTGCAGCTCC AACATGTTTT ACTTTCTATT 300
TACTAAAATA AACTTCCTCT TTCATGATGA CTTTGGAAAA TGGACTCTGG ACCACTTGGA 360
GTTCATAAAG ACACGAATCA GGCTATCTTA GTCCTGACAT GAATCACTTT CTCTCCCCAC 420
CCATTTCCAC AGATGCGTGG GTAATTTGGT CTCACTGCAT CCCTCCTGCT GTCTTCAGGA 480
GGATTTCCGC CACCTCGGCA GCATGAGTCA AAATGGATCA TCCTCCCCGC CTCACCGCTT 540
AACGAACTGA GGTGTGTGTT GGAGCTGAAT GTTTACAACA CAAAACCACC AACCATCTTG 600
TTTCTTCATG TTTTGATGGC CCAGAAGCTG AGCTGCAGGG AGAGGACCTC CCCATTCCTG 660
CGTAGAAGAC AGGGGTCTTC TTATGTCTTA ACTTTTCTTG ACTACTGTTT GGCTTTCAGT 720
GAATGCTTCA AAAGTTCTAC CCTGTGTCCA GCACCCCAGG TCTTGATGGA TAAAAATTCT 780
CAGCACCTAA GCTGATCTTC ATTCCTCATT TCCAGCCACA GCTCAAGGGG TTTGCAGTCT 840
GTCTTTGGAA ATGACTCAAC 860
|
